Invention Grant
- Patent Title: Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
-
Application No.: US15179268Application Date: 2016-06-10
-
Publication No.: US09962377B2Publication Date: 2018-05-08
- Inventor: Ulrich Kautz
- Applicant: TAKEDA GMBH
- Applicant Address: DE Constance
- Assignee: TAKEDA GMBH
- Current Assignee: TAKEDA GMBH
- Current Assignee Address: DE Constance
- Agency: Nath, Goldberg & Meyer
- Agent Joshua B. Goldberg; Tanya E. Harkins
- Priority: EP04004973 20040303; EP04106359 20041207
- Main IPC: A61K31/473
- IPC: A61K31/473 ; C07D401/04 ; C07D401/14 ; C07D405/04 ; C07D413/04 ; C07D417/04 ; C07D417/14 ; C07D471/04 ; A61K31/4985 ; A61K31/506 ; A61K31/5377 ; A61K31/501

Abstract:
Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors, useful in the treatment of areata, endogenous acne, exogenous acne or acne rosacea.
Public/Granted literature
- US20160279120A1 NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS Public/Granted day:2016-09-29
Information query
IPC分类: